
Louise Wang Zhiying Humphrey
Supervisory Patent Examiner (ID: 4289, Phone: (571)272-5543 , Office: P/1657 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1657, 1648 |
| Total Applications | 627 |
| Issued Applications | 267 |
| Pending Applications | 54 |
| Abandoned Applications | 312 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10000347
[patent_doc_number] => 09044420
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-02
[patent_title] => 'Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses'
[patent_app_type] => utility
[patent_app_number] => 13/441502
[patent_app_country] => US
[patent_app_date] => 2012-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 52544
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13441502
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/441502 | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses | Apr 5, 2012 | Issued |
Array
(
[id] => 8707498
[patent_doc_number] => 20130064787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy'
[patent_app_type] => utility
[patent_app_number] => 13/440801
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6475
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13440801
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/440801 | Methods for Treatment of HIV and Other Infections Using a T Cell or Viral Activator and Anti-Retroviral Combination Therapy | Apr 4, 2012 | Abandoned |
Array
(
[id] => 9703613
[patent_doc_number] => 08828673
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-09
[patent_title] => 'Mixed cell diagnostic systems for detection of respiratory, herpes and enteric viruses'
[patent_app_type] => utility
[patent_app_number] => 13/409952
[patent_app_country] => US
[patent_app_date] => 2012-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28340
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13409952
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/409952 | Mixed cell diagnostic systems for detection of respiratory, herpes and enteric viruses | Feb 29, 2012 | Issued |
Array
(
[id] => 9703338
[patent_doc_number] => 08828399
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-09-09
[patent_title] => 'Cytomegalovirus surface protein complex for use in vaccines and as a drug target'
[patent_app_type] => utility
[patent_app_number] => 13/409987
[patent_app_country] => US
[patent_app_date] => 2012-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 18829
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13409987
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/409987 | Cytomegalovirus surface protein complex for use in vaccines and as a drug target | Feb 29, 2012 | Issued |
Array
(
[id] => 8689749
[patent_doc_number] => 08389275
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-05
[patent_title] => 'Fusion proteins of HIV regulatory/accessory proteins'
[patent_app_type] => utility
[patent_app_number] => 13/372706
[patent_app_country] => US
[patent_app_date] => 2012-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7706
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372706
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/372706 | Fusion proteins of HIV regulatory/accessory proteins | Feb 13, 2012 | Issued |
Array
(
[id] => 8227885
[patent_doc_number] => 20120142097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-07
[patent_title] => 'FUSION PROTEINS OF HIV REGULATORY/ACCESSORY PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/372723
[patent_app_country] => US
[patent_app_date] => 2012-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7591
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13372723
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/372723 | Fusion proteins of HIV regulatory/accessory proteins | Feb 13, 2012 | Issued |
Array
(
[id] => 10919741
[patent_doc_number] => 20140322760
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-30
[patent_title] => 'METHOD FOR PRODUCING VIRUS VECTOR FOR GENE TRANSFER'
[patent_app_type] => utility
[patent_app_number] => 13/983191
[patent_app_country] => US
[patent_app_date] => 2012-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4493
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13983191
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/983191 | Method for producing virus vector for gene transfer | Feb 7, 2012 | Issued |
Array
(
[id] => 8335108
[patent_doc_number] => 20120201811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-09
[patent_title] => 'GENERATION AND USE OF FAB, SCFV, AND RELATED BINDING MOLECULES SPECIFIC FOR HIV-1 REV'
[patent_app_type] => utility
[patent_app_number] => 13/366015
[patent_app_country] => US
[patent_app_date] => 2012-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 34869
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13366015
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/366015 | GENERATION AND USE OF FAB, SCFV, AND RELATED BINDING MOLECULES SPECIFIC FOR HIV-1 REV | Feb 2, 2012 | Abandoned |
Array
(
[id] => 9523912
[patent_doc_number] => 08748174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-10
[patent_title] => 'Non-tumorigenic MDCK cell line for propagating viruses'
[patent_app_type] => utility
[patent_app_number] => 13/355252
[patent_app_country] => US
[patent_app_date] => 2012-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 25791
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13355252
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/355252 | Non-tumorigenic MDCK cell line for propagating viruses | Jan 19, 2012 | Issued |
Array
(
[id] => 8744610
[patent_doc_number] => 20130084327
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-04
[patent_title] => 'POLYNUCLEOTIDE ENCODING A TRIM-CYP POLYPEPTIDE, COMPOSITIONS THEREOF, AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/331363
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14784
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13331363
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/331363 | Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same | Dec 19, 2011 | Issued |
Array
(
[id] => 8495482
[patent_doc_number] => 20120294890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'Recombinant Parainfluenza Virus Expression Systems And Vaccines'
[patent_app_type] => utility
[patent_app_number] => 13/329903
[patent_app_country] => US
[patent_app_date] => 2011-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17572
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13329903
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/329903 | Recombinant Parainfluenza Virus Expression Systems And Vaccines | Dec 18, 2011 | Abandoned |
Array
(
[id] => 9041212
[patent_doc_number] => 20130243850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'ADJUVANT'
[patent_app_type] => utility
[patent_app_number] => 13/989176
[patent_app_country] => US
[patent_app_date] => 2011-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11309
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989176
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/989176 | Adjuvant | Nov 22, 2011 | Issued |
Array
(
[id] => 9134401
[patent_doc_number] => 20130295115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING ALPHAVIRUS INFECTION'
[patent_app_type] => utility
[patent_app_number] => 13/885536
[patent_app_country] => US
[patent_app_date] => 2011-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 14012
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13885536
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/885536 | COMPOSITIONS AND METHODS FOR TREATING ALPHAVIRUS INFECTION | Nov 15, 2011 | Abandoned |
Array
(
[id] => 9273322
[patent_doc_number] => 08637252
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-28
[patent_title] => 'Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs'
[patent_app_type] => utility
[patent_app_number] => 13/296370
[patent_app_country] => US
[patent_app_date] => 2011-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 20
[patent_no_of_words] => 22196
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 226
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13296370
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/296370 | Methods and compositions for determining altered susceptibility of HIV-1 to anti-HIV drugs | Nov 14, 2011 | Issued |
Array
(
[id] => 7807548
[patent_doc_number] => 20120058502
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'Method for Identifying Protease Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/294635
[patent_app_country] => US
[patent_app_date] => 2011-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7110
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058502.pdf
[firstpage_image] =>[orig_patent_app_number] => 13294635
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/294635 | Method for identifying protease inhibitors | Nov 10, 2011 | Issued |
Array
(
[id] => 8220773
[patent_doc_number] => 20120134974
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'METHODS FOR REMOVING PLASMA'
[patent_app_type] => utility
[patent_app_number] => 13/282006
[patent_app_country] => US
[patent_app_date] => 2011-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 14361
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13282006
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/282006 | METHODS FOR REMOVING PLASMA | Oct 25, 2011 | Abandoned |
Array
(
[id] => 7766954
[patent_doc_number] => 20120034630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'Circovirus Sequences Associated With Piglet Weight Loss Disease (PWD)'
[patent_app_type] => utility
[patent_app_number] => 13/277582
[patent_app_country] => US
[patent_app_date] => 2011-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 24110
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20120034630.pdf
[firstpage_image] =>[orig_patent_app_number] => 13277582
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/277582 | Circovirus sequences associated with piglet weight loss disease (PWD) | Oct 19, 2011 | Issued |
Array
(
[id] => 7744871
[patent_doc_number] => 20120022246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'Magnetic Pigment'
[patent_app_type] => utility
[patent_app_number] => 13/269195
[patent_app_country] => US
[patent_app_date] => 2011-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7362
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022246.pdf
[firstpage_image] =>[orig_patent_app_number] => 13269195
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/269195 | Magnetic Pigment | Oct 6, 2011 | Abandoned |
Array
(
[id] => 7791560
[patent_doc_number] => 20120053116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'SCYTOVIRIN DOMAIN 1 RELATED POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 13/250309
[patent_app_country] => US
[patent_app_date] => 2011-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13611
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20120053116.pdf
[firstpage_image] =>[orig_patent_app_number] => 13250309
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/250309 | Scytovirin domain 1 related polypeptides | Sep 29, 2011 | Issued |
Array
(
[id] => 8834332
[patent_doc_number] => 08450087
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-28
[patent_title] => 'Use of triplex structure DNA in transferring nucleotide sequences'
[patent_app_type] => utility
[patent_app_number] => 13/238133
[patent_app_country] => US
[patent_app_date] => 2011-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 36
[patent_no_of_words] => 14183
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13238133
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/238133 | Use of triplex structure DNA in transferring nucleotide sequences | Sep 20, 2011 | Issued |